Zydus gets USFDA final approval for Imatinib Mesylate Tablets Medical Dialogues Bureau9 April 2020 1:01 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec®...
Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director Farhat Nasim16 Jun 2019 9:31 AM ISTSanjay Murdeshwar is Country President, Novartis in India and responsible for the company's pharmaceuticals business in the country.New Delhi: Pharma...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....